TY  - CHAP
M1  - Book, Section
TI  - Intestinal Motility Disorders
A1  - McQuaid, Kenneth R.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
Y1  - 2021
N1  - 
T2  - Current Medical Diagnosis & Treatment 2021
AB  - Key  Clinical  Updates  in  Intestinal  Motility  DisordersIn  2019,  a  small  blinded  crossover  trial  of  34  patients  with  confirmed  gastroparesis,  the  serotonin  5-HT4  receptor  agonist,  prucalopride  (currently  FDA  approved  for  treatment  of  chronic  constipation)  demonstrated  significant  improvement  in  gastric  emptying  and  symptoms  compared  with  placebo.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2023/06/09
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1175802346
ER  -